Young Li
Stock Analyst at Jefferies
(0.27)
# 4,046
Out of 4,829 analysts
5
Total ratings
33.33%
Success rate
-24.94%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Initiates: Buy | $72 | $13.75 | +423.64% | 1 | Oct 29, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $84.45 | +36.18% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $0.73 | +71.23% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $36.57 | +64.07% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $11.85 | +288.19% | 1 | Jul 16, 2021 |
RxSight
Oct 29, 2024
Initiates: Buy
Price Target: $72
Current: $13.75
Upside: +423.64%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $84.45
Upside: +36.18%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $0.73
Upside: +71.23%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $36.57
Upside: +64.07%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $11.85
Upside: +288.19%